Fig. 1From: Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseasesFlow diagram of case reports of patients with MPS-II published between January 2008 to April 2018Back to article page